1. Bisphosphonate Therapy for Reduced Bone Mineral Density in Children with Chronic Graft-versus-Host Disease 
Paul A. Carpenter, Paul Hoffmeister, Charles H. Chesnut, Barry Storer, Paula M. Charuhas, Ann E. Woolfrey, Jean E. Sanders 
Biology of Blood and Marrow Transplantation 
Volume 13, Issue 6, Pages (June 2007)
DOI: /j.bbmt
Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Bone mineral density at baseline and after follow-up. Shown for the patients treated without (n = 48) and with (n = 18) bisphosphonates are: (A) the standardized BMD (sBMD) for each patient, together with the median sBMD (filled large squares), at baseline (pre) and at follow-up (post), and (B) the median, 25th, and 75th percentiles (box), and range of the rates of change of sBMD (whiskers).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Annualized bone mineral density at baseline and after follow-up. Shown for the patients treated without (n = 48) and with (n = 18) bisphosphonates are: (A) the BMD Z-scores for each patient, together with the median Z-score (filled large squares), at baseline (pre) and at follow-up (post), and (B) the median, 25th, and 75th percentiles (box), and range of the rates of change of Z-scores (whiskers).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions